Health Condition 1: F418- Other specified anxiety disorders
Conditions
Interventions
Intervention1: Group-I
(Trial group)
: Nasya of trial drug Oil + Standard care of treatment
Chlordiazepoxide (Cap. Librium 10mg)
Intervention2: Group-II
(Comparison group): Standard care of treatment
Sponsors
Dr Pankaj P Surve
Eligibility
Inclusion criteria
Inclusion criteria: Pre-diagnosed case of Anxiety neurosis No discrimination of sex, race, caste and religion Onset between 8 weeks and 2years Subjects with known standard care of treatment Subjects with history of Diabetes mellitus type 2 and mild Hypertension
Exclusion criteria
Exclusion criteria: Diagnosed cases of Schizophrenia Subjects showing repeated Panic attack Subjects diagnosed as Medication-induced anxiety disorder, panic disorders, Post traumatic Stress Disorder Subjects having Specific phobia, Agoraphobia or any other chronic systemic disease as Irritable Bowel Syndrome Severe Kidney Disease Pregnant and Lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reductions in symptoms HAMA Scale of AnxietyTimepoint: 0th day, 8th day, 15th days amd 45thday | — |
Secondary
| Measure | Time frame |
|---|---|
| reduction in symptoms of anxietyTimepoint: after 45 days | — |
Countries
India
Contacts
Public ContactProf Dr Prasanna Gavali
MUHS Nashik and NCIM NewDelhi
Outcome results
None listed